The U.S. Meals and Drug Administration (FDA) has granted Regenerative Medication Superior Remedy (RMAT) designation to KB707, an investigational inhaled immunotherapy being...
Lengthy-term outcomes from the CATNON trial confirmed that including adjuvant temozolomide after radiotherapy considerably improved survival for sufferers with newly recognized IDH-mutant,...
In an interview for CURE Educated Affected person® Updates, Drs. Alexandra Miller, Daniel Orringer and Jonathan Yang mentioned how understanding analysis, biomarker...
